AEON Biopharma, Inc.
AEON Biopharma, Inc.
Your view on AEON
Overview
What the company does, where it operates, and who runs it.
About AEON Biopharma, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Robert Bancroft
- Headquarters
- 4040 Macarthur Boulevard, Newport Beach, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Robert Bancroft
- Headquarters
- 4040 Macarthur Boulevard, Newport Beach, CA, US
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.